Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 23.01 | 44.60 |
| PEG Ratio (TTM) | -0.56 | 0.81 |
| P/S Ratio (TTM) | 0.47 | 7.62 |
| P/B Ratio (TTM) | 0.69 | 47.31 |
| P/FCF Ratio (TTM) | 12.26 | 36.14 |
| Price to 5YR AVG Earnings Ratio | 7.06 | 31.84 |
| Price to 5YR AVG FCF Ratio | 6.12 | 49.79 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.38% | 10.74% |
| ROE (TTM) | 2.95% | 106.30% |
| Net Profit Margin (TTM) | 2.04% | 17.00% |
| ROIC 5YR AVG | 14.83% | 15.49% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 40.89% | 46.06% | 11.35% |
| Revenue | -5.26% | 4.62% | -1.64% |
| Net Income | 41.33% | 48.45% | 12.99% |
| Cash Flow | 1,076.13% | 5.99% | 1.99% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.84 | 1.25 |
| Quick Ratio (TTM) | 2.84 | 1.25 |
| D/E Ratio (TTM) | 0.01 | 4.37 |
| Interest Coverage (TTM) | N/A | 8.15 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 3.43 | 5.68 |
| LTL to 5YR AVG FCF | 0.19 | 7.59 |
| Shares Outstanding Growth 5YR AVG | 1.15% | -0.88% |